LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Monitoring the Coagulation Profile of COVID-19 Patients Using Standard and ClotPro

    Milić, Dragan / Lazarević, Milan / Vuković, Natalija / Kamenov, Aleksandar / Perić, Velimir / Golubović, Mlađan / Stošić, Marija / Spasić, Dimitrije / Stojiljković, Vladimir / Stokanović, Dragana

    Medicina (Kaunas, Lithuania)

    2023  Volume 59, Issue 7

    Abstract: Background and ... ...

    Abstract Background and Objectives
    MeSH term(s) Humans ; Thrombelastography/adverse effects ; Thrombelastography/methods ; COVID-19/complications ; Hemostasis ; Blood Coagulation Disorders/etiology ; Thrombosis/diagnosis ; Thrombosis/etiology ; Fibrinogen ; Inflammation/complications ; Peptide Fragments ; Lipopolysaccharide Receptors
    Chemical Substances antineoplaston A10 (16VY3TM7ZO) ; Fibrinogen (9001-32-5) ; presepsin protein, human ; Peptide Fragments ; Lipopolysaccharide Receptors
    Language English
    Publishing date 2023-06-26
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2188113-3
    ISSN 1648-9144 ; 1010-660X
    ISSN (online) 1648-9144
    ISSN 1010-660X
    DOI 10.3390/medicina59071202
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 6270: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

  2. Article ; Online: Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

    Gauffin, Oskar / Brand, Judith S / Vidlin, Sara Hedfors / Sartori, Daniele / Asikainen, Suvi / Català, Martí / Chalabi, Etir / Dedman, Daniel / Danilovic, Ana / Duarte-Salles, Talita / García Morales, Maria Teresa / Hiltunen, Saara / Jödicke, Annika M / Lazarevic, Milan / Mayer, Miguel A / Miladinovic, Jelena / Mitchell, Joseph / Pistillo, Andrea / Ramírez-Anguita, Juan Manuel /
    Reyes, Carlen / Rudolph, Annette / Sandberg, Lovisa / Savage, Ruth / Schuemie, Martijn / Spasic, Dimitrije / Trinh, Nhung T H / Veljkovic, Nevena / Vujovic, Ankica / de Wilde, Marcel / Zekarias, Alem / Rijnbeek, Peter / Ryan, Patrick / Prieto-Alhambra, Daniel / Norén, G Niklas

    Drug safety

    2023  Volume 46, Issue 12, Page(s) 1335–1352

    Abstract: Introduction: Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and aims to determine if there is sufficient evidence to justify further assessment. Throughout ... ...

    Abstract Introduction: Individual case reports are the main asset in pharmacovigilance signal management. Signal validation is the first stage after signal detection and aims to determine if there is sufficient evidence to justify further assessment. Throughout signal management, a prioritization of signals is continually made. Routinely collected health data can provide relevant contextual information but are primarily used at a later stage in pharmacoepidemiological studies to assess communicated signals.
    Objective: The aim of this study was to examine the feasibility and utility of analysing routine health data from a multinational distributed network to support signal validation and prioritization and to reflect on key user requirements for these analyses to become an integral part of this process.
    Methods: Statistical signal detection was performed in VigiBase, the WHO global database of individual case safety reports, targeting generic manufacturer drugs and 16 prespecified adverse events. During a 5-day study-a-thon, signal validation and prioritization were performed using information from VigiBase, regulatory documents and the scientific literature alongside descriptive analyses of routine health data from 10 partners of the European Health Data and Evidence Network (EHDEN). Databases included in the study were from the UK, Spain, Norway, the Netherlands and Serbia, capturing records from primary care and/or hospitals.
    Results: Ninety-five statistical signals were subjected to signal validation, of which eight were considered for descriptive analyses in the routine health data. Design, execution and interpretation of results from these analyses took up to a few hours for each signal (of which 15-60 minutes were for execution) and informed decisions for five out of eight signals. The impact of insights from the routine health data varied and included possible alternative explanations, potential public health and clinical impact and feasibility of follow-up pharmacoepidemiological studies. Three signals were selected for signal assessment, two of these decisions were supported by insights from the routine health data. Standardization of analytical code, availability of adverse event phenotypes including bridges between different source vocabularies, and governance around the access and use of routine health data were identified as important aspects for future development.
    Conclusions: Analyses of routine health data from a distributed network to support signal validation and prioritization are feasible in the given time limits and can inform decision making. The cost-benefit of integrating these analyses at this stage of signal management requires further research.
    MeSH term(s) Humans ; Pharmacovigilance ; Adverse Drug Reaction Reporting Systems ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Databases, Factual ; Netherlands
    Language English
    Publishing date 2023-10-07
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 1018059-x
    ISSN 1179-1942 ; 0114-5916
    ISSN (online) 1179-1942
    ISSN 0114-5916
    DOI 10.1007/s40264-023-01353-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    Full text online

    More links

    Kategorien

    In stock of ZB MED Cologne/Königswinter

    Zs.A 2127: Show issues Location:
    Je nach Verfügbarkeit (siehe Angabe bei Bestand)
    bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
    Jg. 1995 - 2021: Lesesall (1.OG)
    ab Jg. 2022: Lesesaal (EG)

    Order via subito

    This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

To top